Executive Vice President
Sales & Business Development
Chief Executive Officer
Course Relevance: The Genomic Revolution is upon us. Genetic Testing is now mainstream as over 26M Americans have taken a direct to consumer, at home genetic test. Through genomic insights, individuals and their physicians can now identify hereditary risk, the effectiveness of medication, and optimal treatment options for certain diseases based on an individual’s personal DNA. Clinical grade genetic testing can be integrated into employee benefit programs in a responsible and affordable way. Employers are now evaluating the pros and cons of offering genetic testing to their employees, as well as legal and compliance considerations.
Course Objective: Advanced genomic products are improving healthcare outcomes around the world. Join Tom Wamberg and Nick Bellanca from Wamberg Genomic Advisors on how leading employers are implementing genomic strategies to improve the health of their employees and reduce their healthcare spend. Hereditary Genetic Screening, Pharmacogenomics, and Advanced DNA Testing for Cancer are all discussed in this employer focused presentation.
Course Agenda (1 Hour Presentation):
8:30 a.m. – Presentation Commences
9:30 a.m. – Presentation Concludes
- Check the hotel signs on the day of the meeting to verify the room location
- One (1) CE Credit with the California Department of Insurance (Course # 383150)
- CE is available to members only
- No reservations without payment
Refunds Policy: Registrations canceled less than 72 hours from event date cannot be refunded.
|Ticket Type||Early Registration (by 9/5/19)||After Early Registration (after 9/5/19)|